News
A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive ...
A multinational research team of clinicians and scientists from South Korea and Singapore has published positive findings ...
Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study ...
New York University researchers say a simple, gene-based blood test has shown to be highly accurate in predicting whether ...
A new multicenter study by researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with the National Cancer Institute-funded Clinical Proteomic Tumor Analysis Consortium (CPTAC) ...
INmune Bio partners with UK-based Catapult to enhance cell therapy manufacturing for the production of its cell therapies.
Professor Nicholas Turner, from the Institute of Cancer Research, tells Sky News that capivasertib is a "great success story ...
Four leading companies CTMC, Iovance Therapeutics, KSQ, and TILT Biotherapeutics prognosticate coming successes of new technology approaches to better tumor-infiltrating lymphocyte activities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results